Monitoring of Resistant-Related Genes to Cetuximab in Extracellular Vesicle-Derived DNA from Metastatic Colorectal Cancer Patients
1. Abstract 1.1. Background: Extracellular vesicle derived-DNA (EV DNA) have emerged as attractive diagnostic biomarkers in diseases diagnosis, while its role in metastatic colorectal cancer (mCRC) is unknown. This study aimed to explore the role of EV DNA in monitoring of gene mutations related to drug resistance during therapy with the anti-EGFR antibody cetuximab.